Kenvue Inc KVUE
Regular-session close
After hours · Oct 30, 4:00 PM ET
- YTD
- 0.00%
- 1 year
- 0.00%
- Market cap
- 37.11B
- Revenue (ttm)
- 15.53B
- Profit margin
- 10.88%
- EPS (ttm)
- 0.88
- Shares out
- 1.92B
- P/E ratio
- 21.94
- Forward P/E
- 15.58
- Dividend
- 0.84 (4.35%)
- Ex-dividend date
- Sep 21, 2026
- YTD return
- 0.00%
- 1-year return
- 0.00%
- Volume
- 66.38M
- Avg volume
- 22.41M
- Open
- 19.99
- Previous close
- 19.56
- Day's range
- 19.20 – 20.00
- 52-week range
- 15.94 – 20.13
- Beta
- 0.40
- Analysts
- Hold
- Price target
- 19.50 (+1.0%)
- Earnings date
- Feb 16, 2027
Key statistics
- Enterprise value
- 44.41B
- PEG ratio
- 1.53
- Price / sales
- 2.39
- Price / book
- 3.65
- Dividend yield
- 4.35%
- Payout ratio
- 94.60%
- Revenue growth
- 3.20%
- Free cash flow
- 2.77B
- Total cash
- 1.04B
- Total debt
- 8.34B
- Return on equity
- 16.25%
- Short % of float
- 3.36%
- 50-day average
- 18.40
- 200-day average
- 18.22
Analyst view
Consensus: hold
- Target (low)
- 18.00
- Target (mean)
- 19.50
- Target (high)
- 23.00
- Strong buy1
- Buy1
- Hold10
- Sell0
- Strong sell0
Next earnings
Feb 16, 2027
Expected Feb 16, 2027. Consensus EPS estimate 0.26573.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Feb 16, 2027 | Dec 27, 2026 | 0.28 | — | — | — |
| Oct 30, 2026 | Sep 27, 2026 | 0.2915 | 0.29 | 0.00 | -0.51% |
| Aug 6, 2026 | Jun 28, 2026 | 0.3187 | 0.31 | -0.01 | -2.73% |
| May 7, 2026 | Mar 29, 2026 | 0.2621 | 0.32 | +0.06 | +22.09% |
| Feb 17, 2026 | Dec 28, 2025 | 0.2227 | 0.27 | +0.05 | +21.24% |
| Nov 3, 2025 | Sep 28, 2025 | 0.2602 | 0.28 | +0.02 | +7.61% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 2, 2026 | UBS | main | Neutral | Neutral |
| Aug 11, 2026 | UBS | main | Neutral | Neutral |
| Jul 21, 2026 | Barclays | main | Equal-Weight | Equal-Weight |
| Jul 16, 2026 | UBS | main | Neutral | Neutral |
| Apr 15, 2026 | Citigroup | main | Neutral | Neutral |
| Apr 14, 2026 | Barclays | main | Equal-Weight | Equal-Weight |
About Kenvue Inc
Kenvue Inc. operates as a consumer health company in the United States, rest of North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates in three segments: Self Care, Skin Health and Beauty, and Essential Health. The company offers over-the-counter medicine for cough, cold and allergy, pain care, digestive health, smoking cessation, and eye care, as well as other naturally inspired and self-care products, digital diagnostics, and telemedicine; face and body care, hair, sun, and other care products; oral and baby care, women's health, wound care, and other essential health products; tampons; cosmetics; and vitamins and supplements. It sells its products under the Benadryl, Calpol, Motrin, Nicorette, Rhinocort, Tylenol, Zarbee's Naturals, and Zyrtec; Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Neutrogena, OGX, and Rogaine; BAND-AID, Carefree, Desitin, Johnson's, Listerine, o.b., and Stayfree; and ORSL, Clean & Clear, Versalie, Benylin, Daktarin, Imodium, Johnson's Baby, Johnson's Adult, Maui Moisture, Microlax, Motilium, Neosporin, Neostrata, Pepcid, Pulmicort, Regaine, Sudafed, and Visine/Vispring/Visclear brands. Kenvue Inc. was incorporated in 2022 and is headquartered in Summit, New Jersey.
- Sector
- Consumer Defensive
- Industry
- Household & Personal Products
- Country
- United States
- Website
- kenvue.com
News
Kimberly-Clark: 2027 Recovery And Kenvue Synergies Make It A Buy
The Dividend Portfolio That Covers Your Required Minimum Distribution Without Selling a Share: KMB, BIZD, and SPHD
Can Kimberly-Clark's Kenvue Acquisition Unlock Long-Term Growth?
Kimberly-Clark Corporation Announces Expiration and Final Results of Exchange Offers for Kenvue Notes
Kimberly-Clark Acquires Kenvue. Here's What Investors Need to Know Ahead of Its Nov. 5 Earnings Report.
Kenvue Is Leaving the S&P 500: Here's What It Means for Investors
Kimberly-Clark Completes Acquisition of Kenvue, Creating the Preeminent Global Consumer Health and Wellness Leader
Okta Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600
Kenvue (KVUE) Surpasses Q3 Earnings Estimates
4 Dividend Stocks Yielding at Least 4.35% Across 4 Different Businesses
Your note
Sign in to keep a note on KVUE — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| ALVARADO LUANI | Chief Operating Officer | Conversion of Exercise of derivative security | Mar 9, 2026 | 61,415 |
| LAWSON CARLTON | Officer | Stock Award(Grant) | Oct 1, 2026 | 148,012 |
| MONGON THIBAUT | Chief Executive Officer | Conversion of Exercise of derivative security | Mar 4, 2025 | 216,469 |
| PERRY KIRK L | Chief Executive Officer | Conversion of Exercise of derivative security | Dec 14, 2025 | 62,554 |
| RUH PAUL | Chief Financial Officer | Conversion of Exercise of derivative security | Mar 4, 2025 | 56,198 |
| SMITH JEFFREY CHAD | Director | Purchase | Dec 11, 2025 | 0 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| FMR, LLC | 8.18% | 157,051,418 | 3.03B | Jun 29, 2026 |
| Blackrock Inc. | 7.85% | 150,825,694 | 2.91B | Jun 29, 2026 |
| Vanguard Capital Management LLC | 6.52% | 125,314,564 | 2.42B | Jun 29, 2026 |
| State Street Corporation | 6.33% | 121,619,054 | 2.35B | Jun 29, 2026 |
| Vanguard Portfolio Management LLC | 4.86% | 93,303,762 | 1.80B | Jun 29, 2026 |
| Geode Capital Management, LLC | 2.71% | 52,021,320 | 1.00B | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.17% | 60,959,257 | 1.18B | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard 500 Index Fund | 2.59% | 49,756,164 | 960.79M | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Mid-Cap Index Fund | 2.17% | 41,604,311 | 803.38M | Jun 29, 2026 |
| iShares Trust-iShares Core S&P 500 ETF | 1.33% | 25,594,358 | 494.23M | Sep 29, 2026 |
| Fidelity Concord Street Trust-Fidelity 500 Index Fund | 1.30% | 24,923,436 | 481.27M | Aug 30, 2026 |
| SPDR S&P 500 ETF TRUST-State Street SPDR S&P 500 ETF Trust | 1.24% | 23,820,542 | 459.97M | Sep 29, 2026 |
